T-89
N/A
Report date: 2022/12/07 16:06:55
Base Information
Drug NameT-89
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesTasly Pharmaceuticals Inc
China Registration ClassN/A
Develop Information
Active CompaniesTasly Pharmaceuticals IncArbor Pharmaceuticals IncTianjin Tasly Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A